Opening Welcome - Eric Kaler
The Ohio Discovery Corridor - Tyler Allchin
Why Neuro? - Steve Fening
Overview of Summit & Introduction of Keynote Speaker - Michael Moffitt
Jordi Parramon - With a background in microelectronics, Dr. Parramon began his career in implantable neuromodulation devices at Boston Scientific Neuromodulation, where he directed electronics and firmware, then therapy development efforts. He moved to Verily and advanced their neurostimulation capabilities. Most recently, Dr. Parramon served as CEO and General Partner at Nexus NeuroTech Ventures, where he led the evaluation of numerous neuro therapies and companies, and investments in many of those companies.
This session features some of the unique and nationally distinct clinical programs that are part of the NEO ecosystem.
Session Chair: John Chae; Co-Chair: Aasef Shaikh
Speakers:
Ben Petrie - Spinal Cord Injury Program
Ron Reichers - Neuro Center of Excellence
Robert Fox - Mellen Center for Multiple Sclerosis
Chris Geiger and Stan Bazarek - Peripheral nerve center
This session consists of a series of 3 minute-thesis style talks in a lightning round format, and will highlight several exciting and distinctive neuro research programs with translational potential here in the northeast Ohio region.
Session Chair: Mike Moffitt; Co-Chair: Nathan Makowski
Speakers:
COSMIIC: A modular implantable neuromodulation system - Nathan Makowski
Photobiomodulation to treat neurological disorders - Michael Moffitt
Glial cells and development of therapeutics for neurological disorders - Paul Tesar
Novel approaches to stroke rehabilitation - Debbie Espy
Modulation of Cortical Activity After Ischemic Stroke Using Deep Brain Stimulation in Rats - Hod Dana
Neuromodulation and Brain Computer Interface - Jennifer Sweet
High resolution imaging of peripheral nerves informs neuromodulation advancements – Andrew Shoffstall
Restoring sensation after neural injury - Emily Graczyk
Neuromodulation of the autonomic nervous system - Steve Lewis
MR Fingerprinting of the Brain - Chaitra Badve
How can electrical stimulation suppress seizures? - Dominique Durand
Translation neuroscience in neurodegeneration and neural injury - Ron Yu
From Signals to Action: A Case for Wearable Interventions - Chris Pulliam
Cutting-edge Human Neuroimaging: From Physics to Patients - Stephen Jones
Over lunch, small groups will tackle specific questions on STRENGTHS and OPPORTUNITIES for the translational and neuro business development ecosystem in NEO. The responses will be part of the Strengths and Opportunities Panel Discussion at the end of the day.
Session Chair: Steve Fening; Co-chair: Morgan Carter; Co-Chair: Michael Moffitt
This session will highlight several leverageable resources - institutes, centers, and programs – that support and foster research and translation in the Neuro NEO ecosystem.
Session Chair: Robert Kirsch; Co-Chair: Michael Fu
Research Institutes & Centers - Bob Kirsch
Entrepreneurial Training & Validation Programs - Brian Davis
CTSC of Northern Ohio & Clinical Implementation/Trials - Grace McComsey
Technology Transfer & Venture Offices - Joe Rich
Accelerators & Startup Support - Andrew Cornwell
Neuro companies from NEO will share their success stories, and highlight what has been great (strengths) about the regional neuro ecosystem, and what would have made it better (opportunities).
Session Chair: Morgan Carter; Co-Chair: Michael Moffitt
Speakers:
Maria Bennett - CEO of SPR Therapeutics
Tony Giordano - CEO of NeuroTherapia
Anthony Ignani - CEO of Synapse Biomedical
Jon Snyder - CEO of ActivateNeuro and prior CEO of Neuros Medical
This session will include reports from the critical questions asked and answered during the networking lunch, followed by a discussion with a panel of experts on the implications of these answers for the NeuroNEO ecosystem.
Session Chair: Steve Fening; Co-Chair: Morgan Carter
Moderator: Michael Oakes
Panelists:
Tyler Allchin will close out the day with next steps, including the most immediate - a networking reception.